Capability
BioSistemika d.o.o. (Slovenia) – Strategic-Technological Analysis
What lab-automation, bioinformatics and DNA-data-storage solutions has BioSistemika developed?
BioSistemika d.o.o. is a Slovenian deep-tech company at the intersection of biotechnology. Defence-finance analysis; 29-page sourced DFM PDF report.
This public thread presents the concise analytical answer. The complete evidence, source base and assessment are available below.
Part of our Research, Universities & Deep Tech and Defence & Dual-Use Companies coverage →
Original DFM publication · DFM Analysis report · 2025-09-07
BioSistemika d.o.o. is a Slovenian deep-tech company at the intersection of biotechnology and digital innovation. Founded as a spin-off of Slovenia’s National Institute of Biology in 2010, it has evolved from a niche lab software developer into a recognized player in Europe’s bioinformatics and laboratory automation landscape .
The company’s journey reflects the rising importance of biotech and data technology for European strategic autonomy. BioSistemika’s solutions – from smart pipetting aids to cutting-edge DNA data storage – are enabling more efficient laboratories and novel approaches to data management.
This analysis answers: What lab-automation, bioinformatics and DNA-data-storage solutions has BioSistemika developed? How has the 2010 National Institute of Biology spin-off matured from lab software to a recognised player? Which biotech and data-technology markets and partners does BioSistemika serve in Europe? What capability gaps or dependencies affect its role in biotech-driven strategic autonomy?
Key takeaways
- BioSistemika’s solutions – from smart pipetting aids to cutting-edge DNA data storage – are enabling more efficient laboratories and novel approaches to data management.
Choose how to continue
Go deeper on this question
Full sourced report
BioSistemika d.o.o. (Slovenia) – Strategic-Technological Analysis
View the report →
Keep getting the analysis
DFM publishes new analysis on Microelectronics, Quantum & Biotechnology every week.
Original DFM analysis
BioSistemika d.o.o. (Slovenia) – Strategic-Technological Analysis
The publication details above identify the source used for this public thread.
FAQ
What is BioSistemika d.o.o. (Slovenia) – Strategic-Technological Analysis?
is a Slovenian deep-tech company at the intersection of biotechnology and digital innovation.
Why does BioSistemika d.o.o. (Slovenia) – Strategic-Technological Analysis matter for European defence?
The company’s journey reflects the rising importance of biotech and data technology for European strategic autonomy.
Related DFM Platform threads
- Europe's High-Low Arsenal: $50.66bn Pledged to Deep Strike, and the Magazine No Public Record Sets
- UK's £400k Strike Weapon vs the $4m PAC-3 MSE: Why Cheap Autonomy Forces Europe to Buy More Layers, Not Fewer
- PAC-3, SAMP/T and Europe's Missile Constraint: Can Cheap Unmanned Mass Substitute for the Expensive Upper Layer?
Explore this category Strategic Autonomy
Professional requests (internal interest signal — not a marketplace; nothing is charged or promised)
See Professional & Institutional Access — plans, group/institutional seats and contact →
Defence Finance Monitor is an analytical and informational product. It does not constitute investment advice, financial advice or a recommendation to buy or sell securities. Subscriptions run on DFM Analysis. Payments for Professional Packs are processed securely by Stripe at checkout.